Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review highlights the evolution of assessment tools for alopecia areata, revealing newer tools that evaluate beyond scalp hair loss, including psychosocial impact and disease chronicity, which can aid clinicians in developing individualized treatment strategies and enhance research in pediatric dermatology.

In this narrative, Dr. Angela Rodgers shares her experience at Baldie Con 2023, highlighting how attending a community-focused conference helped her understand the psychosocial impacts of chronic illness and the importance of connecting with others who share similar experiences.

In this case study, researchers reported on a 54-year-old woman who developed methotrexate toxicity after mistakenly taking high doses over five days, which led to mucocutaneous lesions and pancytopenia, highlighting the importance of early recognition and treatment of such toxicities.

This source reviews various herbal remedies for treating hair loss, highlighting their potential benefits and reduced side effects compared to synthetic treatments, which often do not deliver lasting results and can cause adverse reactions.

The BASP classification helps predict patient behavior and improve treatment for hair loss.

This report highlights a serious complication associated with low-dose oral minoxidil in treating female androgenetic alopecia, an adverse effect previously thought to be rare and minor.

This study reported that over half of recovered COVID-19 patients in Saudi Arabia experienced hair loss, with factors such as high fever, female gender, and prior hair loss significantly associated with incidence of acute telogen effluvium.

Combining scalp photos with hair density and caliber measurements gives a more accurate assessment of hair loss.

This case report highlights that a patient developed pleural effusion due to unintentional oral use of topical minoxidil, despite not having chronic kidney disease.

This review discusses biotin supplementation for dermatological conditions and highlights the lack of strong evidence supporting its efficacy, as well as the potential for laboratory testing interference.

This review discusses the persistence of certain cutaneous changes after pregnancy and highlights the need for further investigation when conditions like telogen effluvium, severe hirsutism, palmar erythema, and striae do not resolve as expected.

This study found that frequent attenders at Cork University Hospital's emergency department accounted for a disproportionate amount of visits and were more likely to require admission for further care.

This source highlights concerns about the safety and efficacy of dietary supplements marketed for hair loss, citing a lack of FDA testing and potential risks such as adverse side effects, interference with medical tests, and withholding of ingredient information.

This review guides readers on how to critically evaluate multiple treatment comparison meta-analyses, offering insights for interpreting and communicating these studies but reporting no new results.

This review argues that case reports remain crucial for identifying new conditions, adverse drug reactions, and medical associations, despite the anecdotal nature of their evidence.

This study examined how different surgical techniques tailored to individual patient characteristics affected outcomes in secondary female hairline correction surgery, finding that patient-specific approaches can lead to satisfactory results.

This review discusses the use of platelet-rich plasma (PRP) in clinical settings and notes the lack of standardization and consensus on its preparation and use; it reports no new clinical results.

This report describes the use of compounded topical preparations to treat two severe psoriasis patients and calls for further studies on their regulation, protocol, and stability evaluation.

This study found that a single session of nanofat combined with platelet-rich plasma significantly increased hair density and thickness in male androgenic alopecia patients compared to platelet-rich plasma alone, with effects partially persisting at 12 months.

This case report highlights a rare adverse event where a patient with inactive idiopathic papilledema experienced increased intracranial pressure after taking spironolactone, which resolved upon discontinuation of the drug.

This study explored the motivations behind 'bro-science' YouTube videos on baldness, finding that posters aim to communicate product benefits, share research and experiences, and create a community around shared solutions.

This review discusses the use of trichoscopy as a valuable diagnostic and prognostic tool for various hair and scalp disorders, reporting no new clinical results.

PRP treatment for hair loss shows promise, with 58% of patients satisfied and most noticing improvement within 6 months.

This study reported that Vatika Enriched Coconut Hair Oil was safe and more effective than regular coconut oil in reducing hair fall, controlling dandruff, and enhancing hair condition, such as shininess and tensile strength, in women over an 8-week period with no adverse effects.

This case series reported three instances where alopecia linked to sodium valproate was reversed after discontinuing the drug.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.

This letter to the editor discusses the prevalence of frontal-vertex baldness and its association with family history in Korean men but reports no new findings.

This publication lists the contributors and affiliations for a research piece but reports no study results or findings.

This case report discusses a 27-month-old girl with vitamin D-dependent rickets type II, who showed minor improvement in skeletal features and alopecia after high-dose oral calcium and vitamin D3 treatment.

This review examines the sexual side effects of 5α-reductase inhibitors like finasteride, highlighting the increased risk of erectile dysfunction, libido reduction, and potential contribution to depression without new clinical findings.